Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Apollomics Inc.
Bayer
Cambridge University Hospitals NHS Foundation Trust
National Cancer Institute (NCI)